Trial NCT04282174

View at ClinicalTrials.gov 
Org. Study IDs: 2019-KOE-001

Last trial update was posted on 2022-09-27

MeSH Interventions

Busulfan Cyclophosphamide Fludarabine Melphalan Thiotepa

MeSH Conditions

Hematologic Diseases Hematologic Neoplasms Leukemia Leukemia, Lymphocytic, Chronic, B-Cell Leukemia, Myelogenous, Chronic, BCR-ABL Positive Leukemia, Myeloid Neoplasms Precursor Cell Lymphoblastic Leukemia-Lymphoma

Other Conditions

Acute Lymphoblastic Leukemia Acute Myeloid Leukemia Chronic Lymphocytic Leukemia Chronic Myelogenous Leukemia Hematologic Malignancy

Stopping Reasons

Study was split into two new studies before the first participant was enrolled.

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID